“Ocular Adverse Events of Systemic Inhibitors of the Epidermal Growth Factor Receptor: Report of 5 Cases” Ophthalmology (2012)

Link to Publication:

https://www.aaojournal.org/article/S0161-6420(12)00227-8/fulltext

Purpose: To describe the ocular effects associated with the administration of the systemic epidermal growth factor receptor (EGFR) inhibitors panitumumab and erlotinib.